Antibodies with improved half-life in ferrets
US9738702B2 · kind B2 · utility
0Cited by
53References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2015 |
| Grant date | Aug 22, 2017 |
| Priority date | — |
| Expiry date | Mar 12, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The antibodies, immunoglobulin constructs, or immunoglobulin fusion proteins whose in vivo half-life is increased in ferrets by a modified ferret IgG Fc region can be useful to test therapeutics in ferrets and ferret models.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.